|
|
|
Reprinted from:
MSA, ProsanosTM Announce Strategic Alliance
Management Science Associates, Inc., (MSA) of Pittsburgh and ProSanosTM
Corporation of La Jolla, CA, today announced a new strategic alliance to
pursue biomedical informatics projects on a national and worldwide basis.
The announcement was made by David B. Parrish, Vice President of MSA's
Medical Division, and Jonathan Morris, MD, President and CEO of ProSanos.
ProSanos (formerly called GenMatics) is a biomedical informatics company
focused on the use of clinically developed disease models to analyze large
amounts of clinical, genomic and biological information. MSA is a world
leader in informatics, data management and analytics. As strategic partners,
the companies will participate in developing a variety of products and
services for the pharmaceutical, biotechnology, and healthcare industries.
"The most exciting medical development in our generation is the rise of
molecular biology, with the prospect of understanding the genetic basis of
disease," Mr. Parrish said. "The integration of genetic information into the
general database will offer extraordinary new insights into the causes,
prevention and treatment of a variety of diseases that have previously
resisted analysis. While we have numerous studies of hypertension, cardiac
disease, proteinuria, renal insufficiency and even genetics, little has been
done to link this information or to correlate how these earlier conditions
may affect the final stages of the disease. For the first time, the ProSanos
approach allows all the available data to be effectively applied." Dr.
Morris said, "Integrating and analyzing the full spectrum of information
allows clients to reduce product development cost and time to market, more
efficiently select appropriate cohorts for clinical targeting and trial, and
more effectively identify new targets for therapeutics and diagnostics. MSA
is an ideal partner for us, with its expertise in data modeling, its
world-class data centers, and its track record in both the governmental and
commercial marketplaces."
As part of this alliance, MSA and ProSanosä have created an advanced
biomedical data center addressing many of the compliance issues associated
with the rigorous security and data integrity standards required by the
biomedical community. This data center integrates MSA’s experience and
expertise in data systems and information management with ProSanos’s
visionary approach to incorporating clinical outcomes with molecular data in
discrete disease models. The center provides the platform for the
sophisticated tools required to analyze today’s genomic and clinical data.
Copyright © 2001 TEQ Magazine. All Rights
Reserved
|
|
